Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:15 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI
NCT05475717 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · PHASE2 · terminated · last registry update 2024-11-21 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Voluntarily suspended the trial due to strategic adjustments” | – | Registry record, CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGER1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2025-09-04Also stopped (withdrawn): Institut National de la Santé Et de la Recherche Médicale, France, Prostaglandin E2 (NCT00545194)
- 2025-04-09Results posted on the registry: Mayo Clinic, a drug against PTGER1 (NCT05199233)
- 2025-01-17Also stopped (terminated): Hospital Kemaman, Intravaginal prostaglandin E2 (NCT05622968)
- 2024-12-27Results posted on the registry: Mayo Clinic, a drug against PTGER1 (NCT04743973)
- 2024-09-03Results posted on the registry: Mayo Clinic, a drug against PTGER1 (NCT04720053)
- 2024-08-28Also stopped (terminated): University Hospital, Limoges, Dinoprostone + Oxytocine (NCT02888041)
- 2024-08-15Results posted on the registry: Centre Hospitalier Departemental Vendee, Dinoprostone (NCT02649920)
- 2024-08-15Also stopped (terminated): Centre Hospitalier Departemental Vendee, Dinoprostone (NCT02649920)
- 2024-07-31Phase 3 first posted: National University Hospital, Singapore, Menopausal hormone therapy + Menopausal hormone therapy + exercise training (NCT06530459)
- 2024-07-19Results posted on the registry: Columbia University, Misoprostol (NCT03670836)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision